Shu-Ping Lan

A Controlled Trial of Plasmapheresis Therapy in Severe Lupus Nephritis

Edmund J. Lewis, Lawrence G. Hunsicker, Shu-Ping Lan et al. · New England Journal of Medicine · 1992 · 481 citations

Medicine, Immunology, Nephrology +13

Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: results from two randomized, placebo-controlled, phase III trials

Kim Papp, Alan Menter, Mai Abe et al. · British Journal of Dermatology · 2015 · 322 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

A randomized phase 2a efficacy and safety trial of the topical <scp>J</scp> anus kinase inhibitor tofacitinib in the treatment of chronic plaque psoriasis

W.C. Ports, Sairah Khan, Shu-Ping Lan et al. · British Journal of Dermatology · 2013 · 202 citations · Full text

Medicine, Dermatology, Pharmacology +13

Randomized Phase 2b Trial of Tofacitinib (CP-690,550) in De Novo Kidney Transplant Patients: Efficacy, Renal Function and Safety at 1 Year

Flavio Vincenti, Stéphan Busque, Philip J. O’Connell et al. · American Journal of Transplantation · 2012 · 162 citations · Full text

Medicine, Nephrology, Pharmacology +17

Progression and Remission of Renal Disease in the Lupus Nephritis Collaborative Study

Andrew S. Levey, Shu-Ping Lan, Howard L. Corwin et al. · Annals of Internal Medicine · 1992 · 132 citations

Medicine, Nephrology, Pharmacotherapy +13